News search

    E.g., 30/11/2024
    E.g., 30/11/2024
    Científicos del grupo de Inmunobiología del CNIC implicados en la publicación. De izquierda a derecha, arriba: Carlos del Fresno, Salvador Iborra, David Sancho, Fran Cueto; abajo: Michel Enamorado, María Martínez-López, Ruth Conde-Garrosa y Sofía Chayeb Khouili
    Research
    28 Sep 2016
    Immunity: CNIC Investigators Identify Ways to Improve Vaccine Design

    The study, published in the journal Immunity, identifies factors necessary for improving vaccines to induce long-duration cellular immunity in barrier tissues such as skin and mucous membranes
    Circulation Research: The CNIC A Successful Vision in Cardiovascular Research
    Research
    20 Sep 2016
    Circulation Research: The CNIC A Successful Vision in Cardiovascular Research

    La revista Circulation Research publica un News & Views sobre los 10 años de investigación en el CNIC
    About the CNIC
    9 Sep 2016
    La investigadora del CNIC Guadalupe Sabio recibe el Premio joven investigador SEBBM-BIOTOOLS

    El Consejo de la SEBBM ha reconocido la excelente calidad de las investigaciones de la investigadora del CNIC
    Ingenuity PET-MRI de Philips de humanos (Equipo híbrido clínico de Tomografía por Emisión de Positrones-Resonancia Magnética) 5
    About the CNIC
    8 Sep 2016
    First call for proposals to access the ReDIB Singular Scientific-Technological Infrastructure (SSTI)

    ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián
    Nestin+ cells in an atherosclerotic plaque (yellow and red) in the brachial artery of an adult mouse. The layer of muscle cells (green) delimits the vessel lumen
    Research
    8 Sep 2016
    Nature Communications: Identify a new mechanism involved in atherosclerosis

    The study, published in Nature Communications, reveals these cells as a possible target for cardiovascular cell therapy
    Polypill
    Research
    23 Aug 2016
    JACC: MINERVA results demonstrate full adherence to guideline-recommended therapies associated with lower rate of a second major cardiovascular event and cost savings

    Journal of the American College of Cardiology (JACC) Publishes Data Assessing the Impact of Medication Adherence on Long-term Cardiovascular Outcomes and Cost
    Jesús Mª Vázquez Cobos, Enrique Calvo, Rebeca Acín Pérez, José Antonio Enríquez, Ana Victoria Lechuga-Vieco, Ignacio Flores, Carlos Torroja, Fátima Sánchez Cabo, Jesús Ruiz-Cabello y Andrés González Guerra.
    Research
    7 Jul 2016
    Nature: The interaction between our two genomes, nuclear and mitochondrial, is the key to healthy aging

    The study, published in Nature, provides information with important implications for mitochondrial donation therapies, which produce children with three genetic parents
    De pie: Prof. Jesús Vázquez, Prof. Francisco Sánchez-Madrid, Dra. Danay Cibrián y Dra. Pilar Martín. Sentados de Izda. a Dcha.: María Laura Sáiz, Dra. Hortensia de la Fuente, Dra. Alessia Ferrarini, Dra. Inmaculada Jorge, Raquel Sánchez-Díaz y Olga Moreno-Gonzalo.
    Research
    5 Jul 2016
    Nature Immunology: Scientists identify an essential role of the immune receptor CD69 in psoriasis

    The study, published in Nature Immunology, opens the way to the possible use of CD69 as a therapeutic target for the control of this disease
    CNIC Scientists David Sancho, Rebeca Acín-Pérez, Michel Enamorado Escalona, José A. Enríquez y Sarai Martínez-Cano
    Research
    28 Jun 2016
    Nature Immunology: Changes to mitochondrial metabolism allow the immune system to adapt to infection

    CNIC scientists reveal how changes in the metabolism of mitochondria allow the cells of the immune system to adapt to living or dead bacteria
    Ignacio Flores, Juan M. Fernández-Alvira, Valentín Fuster, Vicente Andrés y Beatriz Dorado
    Research
    24 May 2016
    JACC: Telomere length in circulating blood cells does not predict asymptomatic atherosclerosis

    Half of patients with CVD show no above-normal risk of developing the disease on the basis of classical risk factors, such as high cholesterol, smoking, lack of exercise, and high blood pressure